BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PA32540: Phase III delayed

FDA informed Pozen that it was conducting an internal review on the acceptability of using endoscopic gastric ulcers as a primary endpoint for a pair of Phase III trials of PA32540. The company submitted an SPA for PA32540 in June, and Phase...

Read the full 188 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >